Monday 15 June 2026

The Pharma Letter Podcast — Episode 27 — How to develop cancer drugs faster, with Ellipses Pharma

Biotechnology
Simon Wentworth
23 January 2024
episode-27-big

More on this story...

Pharmaceutical
The trust complex - strengthening the fundamentals of communications is more important than ever
8 February 2024
Biotechnology
Ellipses’ selective RET inhibitor granted Fast Track designation by FDA
7 March 2024
Pharmaceutical
Doubling down on deep customer insights to inform value demonstration
5 February 2024
Pharmaceutical
Positive pharma report finds increased funding, productivity and product launches in 2023
26 February 2024




Companies featured in this story

More ones to watch >




Today's issue

Positive Phase III results for Intellia’s lonvo-z
Biotechnology
Positive Phase III results for Intellia’s lonvo-z
15 June 2026
Biotechnology
FDA approves Keytruda-Welireg regimen for high-risk kidney cancer after surgery
15 June 2026
Pharmaceutical
Regulatory round-up: 15 June 2026
15 June 2026
Pharmaceutical
Zepzelca fails Phase III test in relapsed small-cell lung cancer
15 June 2026
Pharmaceutical
EFPIA says wider patent incentive could draw $52 billion to Europe
15 June 2026
Pharmaceutical
AI’s pharma opportunity moves from discovery to factory floor
15 June 2026
Biotechnology
WHO names Fiocruz as biomanufacturing training hub for Americas
15 June 2026


Company Spotlight

Avidity Biosciences
A San Diego-based biotechnology company that pioneered muscle-targeted RNA delivery through its proprietary Antibody Oligonucleotide Conjugate platform, Avidity Biosciences was acquired by Novartis in February 2026 for approximately $12 billion.


More Features in Biotechnology

Positive Phase III results for Intellia’s lonvo-z
15 June 2026
FDA approves Keytruda-Welireg regimen for high-risk kidney cancer after surgery
15 June 2026
WHO names Fiocruz as biomanufacturing training hub for Americas
15 June 2026
Hansa Biopharma appoints Adam Cutler as new CFO
15 June 2026


Copyright © The Pharma Letter 2026

 |  Headless Content Management with Blaze